Clinical performance of digital cervicography and cytology for cervical cancer screening in HIV-infected women in Lusaka, Zambia.

Simple item page
dc.contributor.authorBateman, Allen C.
dc.contributor.authorParham, Groesbeck P.
dc.contributor.authorSahasrabuddhe, Vikrant V.
dc.contributor.authorMwanahamuntu, Mulindi H.
dc.contributor.authorKapambwe, Sharon
dc.contributor.authorKatundu, Katundu
dc.contributor.authorNkole, Theresa
dc.contributor.authorMulundika, Jacqueline
dc.contributor.authorPfaendler, Krista S.
dc.contributor.authorHicks, Michael L
dc.contributor.authorShibemba, Aaron
dc.contributor.authorVermund, Sten H.
dc.contributor.authorStringer, Jeffrey S.
dc.contributor.authorChibwesha, Carla J.
dc.date.accessioned2025-09-17T10:27:38Z
dc.date.issued2014-Oct-01
dc.description.abstractAlthough there is a growing literature on the clinical performance of visual inspection with acetic acid in HIV-infected women, to the best of our knowledge, none have studied visual inspection with acetic acid enhanced by digital cervicography. We estimated clinical performance of cervicography and cytology to detect cervical intraepithelial neoplasia grade 2 or worse. Sensitivity and specificity of cervicography were 84% [95% confidence interval (CI): 72 to 91) and 58% (95% CI: 52 to 64). At the high-grade squamous intraepithelial lesion or worse cutoff for cytology, sensitivity and specificity were 61% (95% CI: 48 to 72) and 58% (95% CI: 52 to 64). In our study, cervicography seems to be as good as cytology in HIV-infected women.
dc.identifier.doi10.1097/QAI.0000000000000270
dc.identifier.urihttps://pubs.cidrz.org/handle/123456789/12280
dc.identifier.uri.pubmedhttps://pubmed.ncbi.nlm.nih.gov/24977474/
dc.relation.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.sourceJournal of acquired immune deficiency syndromes (1999)
dc.titleClinical performance of digital cervicography and cytology for cervical cancer screening in HIV-infected women in Lusaka, Zambia.

Files

Collections

Published